Sign in

CIK 0001514183

  • Non-accelerated filer
  • Smaller reporting company

Silo Pharma, Inc.

Sign in to watch
Ticker
SILO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
462137136
Phone
+1 718-400-9031
Business address
677 N. WASHINGTON BLVD, SARASOTA, FL, 34236
Former names
Uppercut Brands, Inc., Point Capital, Inc., Gold Swap Inc
  1. 4 Open-market buy CEO and President bought 2,900 shares at an average $1.46 ($4,235)
  2. 4 Open-market buy Chief Financial Officer bought 1,000 shares at $2.13 ($2,126)
  3. 4 Open-market buy CEO and President bought 3,000 shares at an average $2.07 ($6,204)
  4. 4 Open-market buy CEO and President bought 330 shares at an average $2.70 ($890)
  5. 4 Open-market buy CEO and President bought 750 shares at an average $3.10 ($2,328)
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 4 Open-market buy CEO, CFO and President bought 13,080 shares at $0.11 ($1,500)
  9. 4/A Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Open-market buy Chief Executive Officer bought 22,500 shares at an average $0.14 ($3,187)
  13. 4/A Grant or award CEO, CFO and President acquired 7,630,949 shares (grant or award)
  14. 4 Open-market buy CEO, CFO and President bought 58,114 shares at an average $0.00 ($281)
  15. 3 Insider Initial Statement of Ownership
  16. 3 Insider Initial Statement of Ownership
  17. 4 Grant or award CHIEF EXECUTIVE OFFICER acquired 7,630,949 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 3 · 58 filings